Literature DB >> 7689220

Amyloid beta-protein activates tachykinin receptors and inositol trisphosphate accumulation by synergy with glutamate.

H Kimura1, D Schubert.   

Abstract

The biological function of the soluble form of the amyloid beta-protein (ABP) was examined by assaying its interaction with neuronal receptors expressed in Xenopus oocytes. ABP weakly activated tachykinin receptors, but in the presence of N-methyl-D-aspartate and alpha-amino-3-hydroxy-5-methylisoxazole-4- propionate-type glutamate receptors ABP-induced responses were greatly enhanced. Glutamate and ABP together also induced accumulation of inositol trisphosphate and increases in intracellular Ca2+. These observations suggest that in the presence of glutamate, ABP can activate tachykinin receptors and phosphatidylinositol turnover. ABP may therefore act as a neuromodulatory peptide.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7689220      PMCID: PMC47171          DOI: 10.1073/pnas.90.16.7508

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  cDNA cloning of bovine substance-K receptor through oocyte expression system.

Authors:  Y Masu; K Nakayama; H Tamaki; Y Harada; M Kuno; S Nakanishi
Journal:  Nature       Date:  1987 Oct 29-Nov 4       Impact factor: 49.962

2.  Neurotensin and substance P receptors expressed in Xenopus oocytes by messenger RNA from rat brain.

Authors:  I Parker; K Sumikawa; R Miledi
Journal:  Proc R Soc Lond B Biol Sci       Date:  1986-11-22

3.  Regulation of brain type II Ca2+/calmodulin-dependent protein kinase by autophosphorylation: a Ca2+-triggered molecular switch.

Authors:  S G Miller; M B Kennedy
Journal:  Cell       Date:  1986-03-28       Impact factor: 41.582

4.  Regional distribution of type II Ca2+/calmodulin-dependent protein kinase in rat brain.

Authors:  N E Erondu; M B Kennedy
Journal:  J Neurosci       Date:  1985-12       Impact factor: 6.167

5.  Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease.

Authors:  A Goate; M C Chartier-Harlin; M Mullan; J Brown; F Crawford; L Fidani; L Giuffra; A Haynes; N Irving; L James
Journal:  Nature       Date:  1991-02-21       Impact factor: 49.962

6.  An essential role for postsynaptic calmodulin and protein kinase activity in long-term potentiation.

Authors:  R C Malenka; J A Kauer; D J Perkel; M D Mauk; P T Kelly; R A Nicoll; M N Waxham
Journal:  Nature       Date:  1989-08-17       Impact factor: 49.962

7.  Distribution of protein kinase C-like immunoreactive neurons in rat brain.

Authors:  N Saito; U Kikkawa; Y Nishizuka; C Tanaka
Journal:  J Neurosci       Date:  1988-02       Impact factor: 6.167

8.  Amyloid plaque core protein in Alzheimer disease and Down syndrome.

Authors:  C L Masters; G Simms; N A Weinman; G Multhaup; B L McDonald; K Beyreuther
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

9.  Release of excess amyloid beta protein from a mutant amyloid beta protein precursor.

Authors:  X D Cai; T E Golde; S G Younkin
Journal:  Science       Date:  1993-01-22       Impact factor: 47.728

10.  Biological evaluation of substance P antagonists.

Authors:  K Folkers; R Håkanson; J Hörig; J C Xu; S Leander
Journal:  Br J Pharmacol       Date:  1984-10       Impact factor: 8.739

View more
  7 in total

Review 1.  Amyloid beta peptide membrane perturbation is the basis for its biological effects.

Authors:  J N Kanfer; G Sorrentino; D S Sitar
Journal:  Neurochem Res       Date:  1999-12       Impact factor: 3.996

2.  Theoretical models of the ion channel structure of amyloid beta-protein.

Authors:  S R Durell; H R Guy; N Arispe; E Rojas; H B Pollard
Journal:  Biophys J       Date:  1994-12       Impact factor: 4.033

3.  Topography of a binding site for small amnestic peptides deduced from structure-activity studies: relation to amnestic effect of amyloid beta protein.

Authors:  J F Flood; E Roberts; M A Sherman; B E Kaplan; J E Morley
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-04       Impact factor: 11.205

4.  Comparative studies on [Ca2+]i-level of fibroblasts from Alzheimer patients and control individuals.

Authors:  A Palotás; J Kálmán; G Laskay; A Juhász; Z Janka; B Penke
Journal:  Neurochem Res       Date:  2001-07       Impact factor: 3.996

5.  Transcription factor NF-kappaB is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease.

Authors:  B Kaltschmidt; M Uherek; B Volk; P A Baeuerle; C Kaltschmidt
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

6.  Comparative studies on peptides representing the so-called tachykinin-like region of the Alzheimer Abeta peptide [Abeta(25-35)].

Authors:  O M El-Agnaf; G B Irvine; G Fitzpatrick; W K Glass; D J Guthrie
Journal:  Biochem J       Date:  1998-12-01       Impact factor: 3.857

Review 7.  Changes in protein kinases in brain aging and Alzheimer's disease. Implications for drug therapy.

Authors:  L W Jin; T Saitoh
Journal:  Drugs Aging       Date:  1995-02       Impact factor: 3.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.